MedPath

Austrian Breast & Colorectal Cancer Study Group

Austrian Breast & Colorectal Cancer Study Group logo
🇦🇹Austria
Ownership
Private
Established
1984-01-01
Employees
51
Market Cap
-
Website
http://www.abcsg.com

Randomized Neoadjuvant Study of Epirubicin and Docetaxel With/Without Capecitabine in Early Breast Cancer

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2006-04-03
Last Posted Date
2011-12-30
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
536
Registration Number
NCT00309556
Locations
🇦🇹

Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria

🇦🇹

State Hospital Klagenfurt, Klagenfurt, Carinthia, Austria

🇦🇹

Hospital Guessing, Guessing, Burgenland, Austria

and more 23 locations

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Phase 3
Terminated
Conditions
Rectal Cancer Dukes B, Dukes C
First Posted Date
2006-04-03
Last Posted Date
2006-04-03
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
700
Registration Number
NCT00309517
Locations
🇦🇹

Hospital Baden, Baden bei Wien, Lower Austria, Austria

🇦🇹

Hospital Hainburg, Hainburg, Lower Austria, Austria

🇦🇹

Hospital Oberpullendorf, Oberpullendorf, Burgenland, Austria

and more 5 locations

Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C

Phase 3
Completed
Conditions
Colon Cancer Stage III
First Posted Date
2006-04-03
Last Posted Date
2006-04-03
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
598
Registration Number
NCT00309530
Locations
🇦🇹

Hospital St. Vinzenz, Zams, Tyrol, Austria

🇦🇹

Hospital Guessing, Guessing, Burgenland, Austria

🇦🇹

Medical University of Graz, Oncology, Graz, Styria, Austria

and more 13 locations

Randomized Trial on Adjuvant Chemotherapy in Colon Carcinoma Dukes B

Phase 3
Completed
Conditions
Colon Cancer Stage II
First Posted Date
2006-04-03
Last Posted Date
2006-04-03
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
636
Registration Number
NCT00309543
Locations
🇦🇹

Hospital Hainburg, Hainburg, Lower Austria, Austria

🇦🇹

Hospital Oberpullendorf, Oberpullendorf, Burgenland, Austria

🇦🇹

Medical University Vienna, General Hospital, Vienna, Austria

and more 15 locations

Preoperative Combined Radiochemotherapy for Patients With Rectal Carcinoma

Phase 2
Completed
Conditions
Rectal Cancer
Interventions
First Posted Date
2006-02-28
Last Posted Date
2013-12-31
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
60
Registration Number
NCT00297141
Locations
🇦🇹

Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria

🇦🇹

Paracelsus Medical University Salzburg - Oncology, Salzburg, Austria

🇦🇹

Medical University of Graz, Oncology, Graz, Styria, Austria

and more 5 locations

Preoperative Chemoradiation With Capecitabine and Cetuximab

Phase 2
Completed
Conditions
Rectal Cancer
Interventions
First Posted Date
2006-02-28
Last Posted Date
2011-12-30
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
31
Registration Number
NCT00297128
Locations
🇦🇹

Medical University of Graz, Oncology, Graz, Styria, Austria

🇦🇹

Hospital Wiener Neustadt, Surgery, Wiener Neustadt, Lower Austria, Austria

🇦🇹

Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria

and more 7 locations

Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid

Phase 3
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2006-02-24
Last Posted Date
2024-03-15
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
1803
Registration Number
NCT00295646
Locations
🇦🇹

State Hospital Klagenfurt, Surgery, Klagenfurt, Carinthia, Austria

🇦🇹

State Hospital Klagenfurt, Klagenfurt, Carinthia, Austria

🇩🇪

Medical University Kiel, Kiel, Schleswig-Holstein, Germany

and more 69 locations

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Phase 2
Completed
Conditions
Breast Cancer
First Posted Date
2006-02-15
Last Posted Date
2006-09-19
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Target Recruit Count
98
Registration Number
NCT00291798
Locations
🇦🇹

Hospital of Guessing, Guessing, Burgenland, Austria

🇦🇹

Hospital of Wiener Neustadt, Wiener Neustadt, Lower Austria, Austria

🇦🇹

Gynaegological Medical University of Graz, Graz, Styria, Austria

and more 8 locations
© Copyright 2025. All Rights Reserved by MedPath